Evidence map›Paper›PMID 36968835›Full record

ArticleFrontiers in medicine2023

Constructing a prediction model of inflammatory bowel disease recurrence based on factors affecting the quality of life.

Maojuan Li, Yan Tao, Yang Sun, Jing Wu, Fengrui Zhang, Yunling Wen, Min Gong, Jingxian Yan, Hao Liang, Xinyu Bai and 2 more

Full text read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maojuan LiDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Yan TaoDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Yang SunDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Jing WuDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Fengrui ZhangDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Yunling WenDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Min GongDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Jingxian YanDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Hao LiangDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Xinyu BaiDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Junkun NiuDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Yinglei MiaoDepartment of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This study aimed to determine the factors affecting the quality of life of patients with inflammatory bowel disease (IBD) and to construct a disease recurrence prediction model based on these influencing factors. Methods: A prospective, single-center study in China was conducted between October 2020 and March 2021. The quality of life of patients was assessed using the Inflammatory Bowel Disease Questionnaire (IBDQ). Multiple stepwise regression analysis was used to analyze the factors influencing the quality of life of patients with IBD. The chi-square test and the point-biserial correlation analysis were performed to identify factors associated with clinical recurrence. A binary logistic regression model was constructed to predict the recurrence. The receiver operating characteristic curve was used to evaluate the prediction model. Patients with IBD from April 2021 to June 2021 were randomly included for model verification to evaluate the disease recurrence prediction model. Results: The average IBDQ score of patients with IBD was 172.2 ± 35.0 (decreased by 23.2%). The scores of all dimensions of the IBDQ were decreased, especially emotional function and systemic symptoms. Disease activity, age, extraintestinal manifestations (EIMs), and annual household income were important factors influencing the IBDQ scores of patients with ulcerative colitis, and these accounted for ~57.0% of the factors affecting the quality of life. Disease activity, EIMs, and occupational stress were important factors influencing the IBDQ scores of patients with Crohn's disease, and they accounted for approximately 75.1% of the factors affecting the quality of life. Annual household income, occupational stress, and IBDQ scores were independent risk factors for recurrence. The area under the curve of the recurrence prediction model was 81.1%. The sensitivity and specificity were 81.7 and 71.7%, respectively. The Youden index of the model was 0.534. The established recurrence prediction model has good discriminant validity in the validation cohort. Conclusion: The quality of life of patients with IBD was generally poor. The use of factors affecting the quality of life to predict disease recurrence has high predictive value and can support the management of IBD by selecting patients at a higher risk for relapse.

Indexed as

inflammatory bowel diseaseinfluencing factorsprediction modelquality of liferecurrence

Identifiers

PMID36968835
PMCPMC10034041

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read56
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.